Atlas Trials

Immune-related Adverse Event

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Immune-related Adverse Event

RecordFirmDate
Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors (NCT05799898)Institut Mutualiste Montsouris2022-03-01
Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors (NCT05699915)Algemeen Ziekenhuis Maria Middelares2022-01-07
Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype (NCT05700565)Lucie Heinzerling2022-01-01
Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment (NCT05813418)Centre Hospitalier Universitaire, Amiens2021-07-02
Efficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction Adenocarcinoma (NCT06440811)Xijing Hospital2021-01-01
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis (NCT04305145)Massachusetts General Hospital2020-08-31
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology (NCT03948724)Institut Cancerologie de l'Ouest2019-12-11
Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors (NCT05544292)Diakonhjemmet Hospital2018-03-05

Track Immune-related Adverse Event automatically

Every clearance here is in the API, with alerts when new ones post.